The Illinois General Assembly recently approved House Bill 2371, known as the Patient Access to Pharmacy Protection Act, aiming to safeguard access to affordable medications and strengthen healthcare services across the state. The legislation responds to growing concerns about the federal 340B drug pricing program, which has supported safety-net hospitals, health centers, and clinics for over three decades by allowing those providers to stretch limited resources further when serving vulnerable populations.

The 340B program requires pharmaceutical companies to offer discounted outpatient prescription drugs to these providers, who in turn care for a disproportionate share of low-income and medically complex patients. This includes many individuals reliant on Medicare and Medicaid, which do not always cover the full cost of care. In exchange, pharmaceutical companies gain access to the Medicare and Medicaid markets, which together account for roughly half of all Americans.

Loyola Medicine, a major healthcare provider in Illinois, highlighted its dependence on the 340B program to serve patients with complex needs, such as those requiring burn, trauma, and transplant care. According to the organization, nearly 75% of its patients are insured by Medicare or Medicaid, while 2% have no insurance coverage at all. Loyola Medicine emphasizes that the savings acquired through the 340B program are reinvested into community-focused initiatives rather than treated as profits. One example cited is the "Meds to Beds" program, which helps patients leave the hospital with their prescriptions and clear guidance from pharmacists. The program reportedly has reduced hospital readmissions by 44%, benefiting both patient health outcomes and cost containment.

However, advocates say the program faces increasing threats as pharmaceutical companies have tightened access to 340B discounts, particularly affecting contract pharmacies that provide convenient medication access close to patients’ homes. These restrictions place vulnerable groups, including seniors and low-income residents, at risk of reduced access to necessary medications.

House Bill 2371 is designed to counter these challenges by protecting pharmacy relationships vital to the delivery of affordable drugs and ensuring Illinois residents can continue obtaining medications within their communities. Supporters argue that without the resources provided by 340B, hospitals like Loyola Medicine might be forced to reduce services, limit care access, or discontinue essential programs, resulting in patients needing to travel farther or foregoing care altogether.

The bill was sent to Governor JB Pritzker, with advocates urging him to sign it into law to preserve patient access and maintain the ability of safety-net providers to serve their most vulnerable patients.